LFA
ANIP icon

LGT Financial Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

LGT Financial Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58
Closed -$3.21K – 326
2024
Q4 		$3.21K Hold
58
– – 0.01% 619
2024
Q3 		$3.46K Hold
58
– – 0.01% 603
2024
Q2 		$3.69K Hold
58
– – 0.01% 643
2024
Q1 		$4.01K Hold
58
– – ﹤0.01% 655
2023
Q4 		$3.2K Hold
58
– – ﹤0.01% 711
2023
Q3 		$3.37K Buy
+58
New +$3.35K ﹤0.01% 700

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

LGT Financial Advisors's ANIP Position: Q1 2025 in Review

LGT Financial Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2025, closing a stake of 58 shares — an estimated $3.21K sold.

LGT Financial Advisors first reported a position in ANIP in Q3 2023 and held it in 6 quarters. The position peaked at $4.01K in Q1 2024. 230 funds tracked by Wall St. Rank hold ANIP as of Q1 2025.

  • LGT Financial Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 58 ANI Pharmaceuticals shares in Q1 2025, an estimated $3.21K.
  • LGT Financial Advisors first reported a position in ANI Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • LGT Financial Advisors's ANI Pharmaceuticals position peaked at $4.01K in Q1 2024.
  • 230 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2025.

Based on LGT Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.